ONCO-NX
Onco-NX Ltd is the University of Salford drug discovery spin-out company, dedicated to the discovery of new promising anticancer agents.
ONCO-NX
Industry:
Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Salford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.onco-nx.com
Total Employee:
1+
Status:
Active
Total Funding:
50 K GBP
Technology used in webpage:
Domain Not Resolving
Investors List
The North West Fund
The North West Fund investment in Seed Round - Onco-NX
More informations about "Onco-NX"
Onco-NX Company Profile 2024: Valuation, Investors, Acquisition
Onco-NXās primary industry is Drug Discovery. Is Onco-NX a private or public company? Onco-NX is a Private company. What is Onco-NXās current revenue? The current revenue for Onco ā¦See details»
Onco-NX - VentureRadar
Onco-NXās main activity is dedicated to drug discovery and development in the field of Oncology. The company has an emerging pipeline of opportunities. Based in the University of Salford, ā¦See details»
Onco-NX - Funding, Financials, Valuation & Investors - Crunchbase
Onco-NX Ltd is the University of Salford drug discovery spin-out company, dedicated to the discovery of new promising anticancer agents. Search Crunchbase. ... How much funding has ā¦See details»
Onco-NX - Crunchbase
Onco-NX Ltd is the University of Salford drug discovery spin-out company, dedicated to the discovery of new promising anticancer agents. Search Crunchbase. Start Free Trial . Chrome ā¦See details»
Onco-NX - Products, Competitors, Financials, Employees, ā¦
Onco-NX Ltd is the University of Salford drug discovery spin-out company, dedicated to the discovery of new promising anticancer agents. The company is focused on the development of ā¦See details»
Onco-NX - Company Profile - Tracxn
Nov 16, 2024 Onco-NX - Tumor cell targeted small molecule drugs for cancer. Raised a total funding of $80K over 1 round from 1 investor. Onco-NX has 2868 competitors.See details»
Incanthera acquires Onco-NX Ltd
The acquisition between Incanthera and Onco-NX means they will be able to broaden and expand their drug development pipeline from a new Manchester base in addition to their Liverpool ā¦See details»
Onco-NX Ltd - Company Profile and News - Bloomberg Markets
Company profile page for Onco-NX Ltd including stock price, company news, executives, board members, and contact informationSee details»
Onco-Nx | Biotechnology | The Pharmaletter | The Pharmaletter
Onco-Nx is focused on the development of therapeutics which selectively target tumour cells without harming healthy cells thus minimizing or even eliminating undesired side effects. Onco ā¦See details»
TEAM - iQure Pharma
A physicist and business manager by training, Pawel is driven entrepreneur which successfully set-up and managed university oncology focused spin-off Onco-NX Ltd sold in 2014. Pawel ā¦See details»
Cancer Drug Companies Combine Expertise in Merger
Mar 17, 2014 NORTH West oncology company Incanthera Ltd has acquired University of Salford drug discovery spin-out Onco-NX Ltd. The deal represents the first successful sale of a spin ā¦See details»
Onco-NX - Updates, News, Events, Signals & Triggers - Crunchbase
Onco-NX Ltd is the University of Salford drug discovery spin-out company, dedicated to the discovery of new promising anticancer agents. Search Crunchbase. Start Free Trial . Chrome ā¦See details»
Pd (Onco-NX) - Drug Targets, Indications, Patents - Synapse
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»
Onco-NX - CB Insights
Explore {Onco-NX's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Onco-NX CEO, Founder, Key ā¦See details»
Oncology Analytics Announces Rebrand to OncoHealth - PR ā¦
ATLANTA, Sept. 20, 2021 /PRNewswire/ -- Oncology Analytics, the evidence-based digital health company purpose-built for oncology, announced today that it is changing its name to ā¦See details»
Incanthera acquires Onco-NX - 2014-03-10 - Crunchbase
Incanthera acquires Onco-NX on 2014-03-10 for an undisclosed amount. Onco-NX Onco-NX Ltd is the University of Salford drug discovery spin-out company, dedicated to the discovery of ā¦See details»
Impact of oncotype Dx score on treatment and long-term outcomes.
May 28, 2021 Background: Oncotype dx is a 21 gene breast cancer assay that helps predict benefit of chemotherapy in early-stage hormone receptor positive (HR+), HER2 negative, 0 to ā¦See details»
Registered Nurse (RN) - Women's Health Gyn Onco... Job
Here, you are part of an organization on the cutting edge - helping to bring new technologies, breakthrough treatments and community education to countless men, women and children. ā¦See details»
Onco-NX - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Onco-NX . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. About. Onco-NX is ā¦See details»